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Down syndrome (DS), the most frequent genetic disorder
leading to mental retardation is caused by partial/complete
triplication of human chromosome 21 (Hsa21). The differ-
ential expression of genes located on extra chromosome
21 is assumed responsible for phenotypic abnormalities
but this gene dosage hypothesis has not been assessed on
genome-wide basis. The gene expression patterns related
to phenotypic abnormalities may provide insights into
their roles in DS pathogenesis. To analyze the differential
gene expression and understand the molecular mechanism
underlying pathogenesis of DS, we performed global gene
expression profiling in blood samples of 14 DS and 4 nor-
mal subjects using human whole transcriptome microar-
ray. The microarray analysis revealed total of 624 genes
(195 upregulated and 429 down regulated) were differen-
tially expressed in DS patients as compared to control.
Out of the genes present on chromosome-21, a total
of 210 genes were differentially expressed ranging from
1.5 to 5 fold compared to normal individuals. Genes
involved in physiological pathways such as apoptosis and
cell cycle regulation, signal transduction, cell maturation,
and immunity showed dysregulation. Several genes loca-
lized on Hsa21 such as APP, SOD1, DYRK1A, COL6A1
showed differential expression and the levels were con-
served across all DS subjects. Interestingly, several non-
Hsa21 genes such as RCAN3 (Hsa1), ANK3 (Hsa10),
CDK17 (Hsa12) etc., having roles in cardiogenesis, signal
transduction and differentiation of neurons showed
conserved levels of expression across the DS subjects.
Further to investigate the role of microRNAs (miRNAs) in
regulation of gene expression, global miRNA profiling was
performed in 4 DS patients and 1 control using Affymetrix
miRNA 3.0 array. Several Hsa21 miRNAs like miR-99a,
let-7c, miR-125b-2, miR155, miR-802 showed overexpres-
sion effecting the regulation of genes involved in DS
pathogenesis. Our results substantiate that involvement of
non-Hsa21 genes and miRNAs provide etiological basis
for abnormal phenotypes during DS pathogenesis. Our
data lead to more systematic understanding of molecular
mechanism underlying DS pathogenesis and identification
of miRNA based therapeutic targets for better manage-
ment of the disease.
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